“Andexanet: A Reversible Solution to Major Bleeding Due to Xa Inhibitors, According to the ANNEXA-4 Study Published in Circulation Online February 2023 – Access Granted with NTvG Subscription”

2023-05-06 06:00:00

Andexanet has a reversible effect in patients with major bleeding due to Xa inhibitors and ensures adequate haemostasis. Researchers of the ANNEXA-4 study write this down Circulation (2023; online February 20).

Andexanet alfa (‘andexanet’ for short) is a modified form of human factor Xa protein that inhibits the effect of…

The entire content of this article is only accessible to subscribers.

Read 3 articles FREE

Make an account. Free and without obligation.

I want 3x free

Always access to all NTvG publications?

Subscribe today!

Take the introductory subscription

€ 32.95 for 12 weeks!

I want to meet

Do you already have a subscription? login